These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 11011041

  • 1. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
    Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR, Ohlstein EH, Ma XL, Yue TL.
    Eur J Pharmacol; 2000 Oct 06; 406(1):109-16. PubMed ID: 11011041
    [Abstract] [Full Text] [Related]

  • 2. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
    Feuerstein G, Liu GL, Yue TL, Cheng HY, Hieble JP, Arch JR, Ruffolo RR, Ma XL.
    Eur J Pharmacol; 1998 Jun 26; 351(3):341-50. PubMed ID: 9721026
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May 26; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 4. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun 26; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 5. Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart.
    Yue TL, Ma XL, Gu JL, Ruffolo RR, Feuerstein GZ.
    Eur J Pharmacol; 1998 Mar 12; 345(1):61-5. PubMed ID: 9593595
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.
    Khandoudi N, Percevault-Albadine J, Bril A.
    J Cardiovasc Pharmacol; 1998 Sep 12; 32(3):443-51. PubMed ID: 9733358
    [Abstract] [Full Text] [Related]

  • 7. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
    Ma XL, Yue TL, Lopez BL, Barone FC, Christopher TA, Ruffolo RR, Feuerstein GZ.
    J Pharmacol Exp Ther; 1996 Apr 12; 277(1):128-36. PubMed ID: 8613909
    [Abstract] [Full Text] [Related]

  • 8. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.
    Brunvand H, Liu G, Ma XL, Yue TL, Ruffolo RR, Feuerstein GZ.
    Eur J Pharmacol; 1998 Sep 04; 356(2-3):193-8. PubMed ID: 9774249
    [Abstract] [Full Text] [Related]

  • 9. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
    Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, Louden C, Gu JL, Kumar S, Poste G, Ruffolo RR, Feuerstein GZ.
    Circ Res; 1998 Feb 09; 82(2):166-74. PubMed ID: 9468187
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF, Griswold DE, Hillegass LM, Slivjak MJ, Davis PA, DiMartino MJ.
    Pharmacology; 1992 Feb 09; 44(6):297-305. PubMed ID: 1354874
    [Abstract] [Full Text] [Related]

  • 11. Myocardial protection with carvedilol.
    Feuerstein GZ, Hamburger SA, Smith EF, Bril A, Ruffolo RR.
    J Cardiovasc Pharmacol; 1992 Feb 09; 19 Suppl 1():S138-41. PubMed ID: 1378142
    [Abstract] [Full Text] [Related]

  • 12. Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury.
    Igarashi N, Nozawa T, Fujii N, Suzuki T, Matsuki A, Nakadate T, Igawa A, Inoue H.
    Circ J; 2006 Nov 09; 70(11):1509-14. PubMed ID: 17062979
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
    Willette RN, Aiyar N, Yue TL, Mitchell MP, Disa J, Storer BL, Naselsky DP, Stadel JM, Ohlstein EH, Ruffolo RR.
    J Pharmacol Exp Ther; 1999 Apr 09; 289(1):48-53. PubMed ID: 10086986
    [Abstract] [Full Text] [Related]

  • 14. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury.
    Brunvand H, Frłyland L, Hexeberg E, Rynning SE, Berge RK, Grong K.
    Eur J Pharmacol; 1996 Oct 24; 314(1-2):99-107. PubMed ID: 8957224
    [Abstract] [Full Text] [Related]

  • 15. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
    Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, Asakura M, Liao Y, Asano Y, Shintani Y, Kim J, Shinozaki Y, Mori H, Node K, Kitamura S, Tomoike H, Hori M, Kitakaze M.
    Circulation; 2004 Jun 08; 109(22):2773-9. PubMed ID: 15148268
    [Abstract] [Full Text] [Related]

  • 16. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K, Harada N, Uchiba M, Isobe H.
    J Pharmacol Exp Ther; 2004 May 08; 309(2):684-91. PubMed ID: 14764656
    [Abstract] [Full Text] [Related]

  • 17. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2004 Jan 08; 286(1):H83-90. PubMed ID: 14684360
    [Abstract] [Full Text] [Related]

  • 18. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 19. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H, Sakabe A, Maehara K, Maruyama Y.
    Circulation; 2002 Feb 26; 105(8):975-80. PubMed ID: 11864928
    [Abstract] [Full Text] [Related]

  • 20. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
    Kramer JH, Weglicki WB.
    Free Radic Biol Med; 1996 Feb 26; 21(6):813-25. PubMed ID: 8902527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.